News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad
May 28, 2024, 14:05

Timothée Olivier: How applying FDA censoring rules can double the PFS benefit by Vinay Prasad

Timothée Olivier, Medical Oncologist at HUG – Geneva University Hospitals, shared a post on X:

“How applying FDA censoring rules can double the PFS benefit?

Nice coverage by Vinay Prasad in the Drug Development Letter of our paper recently published in EJC!”

Read the article.
Sources: Timothée Olivier/X
.

cancer cancer treatment efficacy clinical trial methodology Drug Development Letter EJC paper FDA censoring rules HUG - Geneva University Hospitals Medical Advancements OncoDaily Oncology oncology research progression-free survival (PFS) benefit regulatory guidelines Timothée Olivier Vinay Prasad
Special Coverage
Blog
Aug 8, 2025, 17:21
New Studies from the ACS - Fight Colorectal Cancer
Blog
Aug 8, 2025, 17:21
World’s Largest Lung Cancer Mental Health Dataset - Lung Cancer Europe
Career
Aug 8, 2025, 17:05
Tony Zhang has been Awarded an Early Stage K99 Award from the NCI/NIH - MVH Lab
Insight
Aug 8, 2025, 16:51
Diego A. Díaz-García: Promising Obrixtamig Data from Journal of Clinical Oncology
Blog
Aug 8, 2025, 16:46
Sami (Papacek) Mansfield: What If Just One Workout Could Help Fight Cancer? 
Insight
Aug 8, 2025, 16:41
Michael Jain: Autologous Stem Cell Boost Fuels the Fire of IEC-HS
Insight
Aug 8, 2025, 16:31
New Series by Nico Gagelmann: Rarity in Hematology - BPDCN
Insight
Aug 8, 2025, 16:31
KEYTRUDA-Chemotherapy Approved by NICE for Advanced Endometrial Cancer in England
Insight
Aug 8, 2025, 16:11
Andrea Necchi: All That You Can’t Leave Behind on MIBC is Online
Blog
Aug 8, 2025, 15:57
Hamza Hashmi: A very Detailed and Helpful Data for QOL and Informed Consent
Insight
Aug 8, 2025, 15:54
Nick Salgia: What Makes RCC Tumors Susceptible to Immunotherapy
Blog
Aug 8, 2025, 15:49
Jennifer Bires: Do You Offer Navigation Services at Your Cancer Center?